2024 / 05 / 13
We’re attending at
TIDES USA 2024
Ajinomoto Bio-Pharma Services will participate in TIDES USA 2024, on May 14 to 17, 2024.
TIDES USA is the Industry’s largest & most renowned event to accelerate Oligo and Peptide Therapeutics to market, and to leading strategies for expediting R&D and improving CMC efficiency.
Ajinomoto Bio-Pharma Services will be making the oral presentation about RNA at the conference.
We look forward to your visit.
| Event Name | TIDES USA 2024 |
|---|---|
| Dates | May 14 (Tue) – 17 (Fri), 2024 |
| Venue | Hynes Convention Center Boston, MA, USA |
Oral Presentation
| Title and Presenters | New Ligation Approach: Technology for High Quality Manufacturing of Over 150 mer RNA Wataru Kurosawa, Ph.D., General Manager of Business Development at Ajinomoto Bio-Pharma Services |
|---|---|
| Abstract | It has never been possible to synthesize partially or heavily modified RNA strands that are over 100 mer long with high quality and high yield using continuous solid phase synthesis or in vitro transcription…until now. In this presentation, We will introduce our new synthetic method for producing high-quality long RNA strands through the enzymatic ligation of several short oligonucleotides. At Aji Bio-Pharma, we have successfully produced RNA strands that are over 150 mer long with base modification. Using this method, we have also synthesized protein-encoding mRNA, which are over 500 mer long. Our revolutionary solution enables the synthesis of partially or heavily modified long RNA strands, which were previously unfeasible to produce using earlier methods. |
| Date, Time and Venue | May 16(Thr), 2024 7:45 |